SENS on Nasdaq
Senseonics (United States)
American industrial instruments for measurement company based in Germantown. Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with RADNOSTIX INC, SYPRIS SOLUTIONS INC or HURCO COMPANIES INC, or pick any stock.
- TickerSENS on Nasdaq1
- IndustryIndustrial Instruments For Measurement, Display, and Control1
- HeadquartersGermantown1
- Websitesenseonics.com
- Incorporated inDE3
- Business address20451 Seneca Meadows Parkway, Germantown, Md 208763
- Filer categoryNon-accelerated filer, Smaller reporting company3
- Legal formCorporation
See how the biggest companies compare on our leaderboards

We are a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (“CGM”) system to improve the lives of people with diabetes by enhancing their ability to manage their disease with relative ease and accuracy. Our implantable CGM system (“Eversense”), including Eversense E3 and Eversense 365 CGM systems are designed to continually and accurately measure glucose levels in people with diabetes via an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to twelve months in the case of Eversense 365 and six months in the case of Eversense E3, as compared to seven to 15 days for non-implantable CGM systems. In September 2024, the 365-day extended life Eversense E3 CGM system was approved by the FDA and, through …5 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Regions
United States brought in 79% of the revenue Senseonics (United States) broke down this way in fiscal 2025.
Regions by year
| Regions | 2024 | 2025 |
|---|---|---|
| United States | $15.3M | $27.9M |
| Outside the United States | $7.2M | $7.3M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue19¢$19.5M
- Research and development30¢$31.6M
- Selling, general and admin51¢$52.5M
Out of $35.3M in revenue.67 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue, net | $35.3M | $22.5M |
| Cost of sales | $19.5M | $21.9M |
| Gross profit | $15.8M | $533.0K |
| Research and development expenses | $31.6M | $41.1M |
| Selling, general and administrative expenses | $52.5M | $34.2M |
| Operating loss | -$68.3M | -$74.8M |
| Interest income | $4.2M | $4.5M |
| Interest expense | -$5.0M | -$8.4M |
| Gain on change in fair value of derivatives | $102.0K | |
| Other expense ( income) | -$23.0K | $59.0K |
| Total other expense, net | -$776.0K | -$3.8M |
| Net Loss | -$69.1M | -$78.6M |
| Unrealized gain on marketable securities | $69.0K | $11.0K |
| Total other comprehensive income | $69.0K | $11.0K |
| Total comprehensive loss | -$69.0M | -$78.6M |
| Basic net loss per common share | -$1.66 | -$2.50 |
| Basic weighted-average shares outstanding | 41.7M shares | 31.5M shares |
| Diluted net loss per common share | -$1.66 | -$2.50 |
| Diluted weighted-average shares outstanding | 41.7M shares | 31.5M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 5 fiscal years (annual) or 6 quarters (quarterly), latest first.6
| Period ending | 2025-12-31 | 2025-10-31 | 2025-09-30 | 2024-12-31 | 2024-10-31 |
|---|---|---|---|---|---|
| Cash and cash equivalents | $40.2M | $74.6M | |||
| Restricted cash | $315.0K | $315.0K | |||
| Short term investments, net | $53.8M | ||||
| Inventory, net | $6.7M | $4.4M | |||
| Prepaid expenses and other current assets | $4.4M | $5.8M | |||
| Total current assets | $117.5M | $91.4M | |||
| Deposits and other assets | $4.5M | $4.9M | |||
| Property, equipment and intangible assets, net | $4.2M | $4.1M | |||
| Total assets | $126.3M | $100.4M | |||
| Accounts payable | $4.1M | $3.2M | |||
| Accrued expenses and other current liabilities | $20.3M | $15.5M | |||
| Note payable, current portion, net | $20.1M | ||||
| Total current liabilities | $24.3M | $38.8M | |||
| Long-term debt and notes payables, net | $35.6M | $34.7M | |||
| Non-current operating lease liabilities | $5.3M | $5.8M | |||
| Total liabilities | $65.2M | $79.3M | |||
| Preferred stock and additional paid-in-capital, subject to possible redemption: $0.001 par value per share; 0 shares and 12,000 shares issued and outstanding as of December 31, 2025 and December 31, 2024 | $37.7M | ||||
| Total temporary equity | $37.7M | ||||
| Common stock, $0.001 par value per share; 70,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 41,265,778 shares and 29,767,561 shares issued and outstanding as of December 31, 2025 and December 31, 2024 | $41.0K | $30.0K | |||
| Additional paid-in capital | $1.1B | $931.3M | |||
| Accumulated other comprehensive income | $69.0K | ||||
| Accumulated deficit | -$1.0B | -$947.9M | |||
| Total stockholders' equity (deficit) | $61.0M | -$16.6M | |||
| Total liabilities, temporary equity and stockholders' equity (deficit) | $126.3M | $100.4M | |||
| Temporary equity, par or stated value per share (in dollars per share) | $0.00 | $0.00 | |||
| Temporary equity, shares issued | 0 shares | 12.0K shares | |||
| Temporary equity, shares outstanding | 0 shares | 12.0K shares | |||
| Common stock, par value per share (in dollars per share) | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common stock, shares authorized | 70.0M shares | 70.0M shares | 1.4B shares | 70.0M shares | |
| Common stock, shares issued | 41.3M shares | 29.8M shares | |||
| Common stock, shares outstanding | 41.3M shares | 29.8M shares |
| Period ending | 2025-12-31 | 2025-10-31 | 2025-09-30 | 2024-12-31 | 2024-10-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | $40.2M | $74.6M | ||||
| Restricted cash | $315.0K | $315.0K | ||||
| Short term investments, net | $53.8M | |||||
| Inventory, net | $6.7M | $4.4M | ||||
| Prepaid expenses and other current assets | $4.4M | $5.8M | ||||
| Total current assets | $117.5M | $91.4M | ||||
| Deposits and other assets | $4.5M | $4.9M | ||||
| Property, equipment and intangible assets, net | $4.2M | $4.1M | ||||
| Total assets | $126.3M | $100.4M | ||||
| Accounts payable | $4.1M | $3.2M | ||||
| Accrued expenses and other current liabilities | $20.3M | $15.5M | ||||
| Note payable, current portion, net | $20.1M | |||||
| Total current liabilities | $24.3M | $38.8M | ||||
| Long-term debt and notes payables, net | $35.6M | $34.7M | ||||
| Non-current operating lease liabilities | $5.3M | $5.8M | ||||
| Total liabilities | $65.2M | $79.3M | ||||
| Preferred stock and additional paid-in-capital, subject to possible redemption: $0.001 par value per share; 0 shares and 12,000 shares issued and outstanding as of December 31, 2025 and December 31, 2024 | $37.7M | |||||
| Total temporary equity | $37.7M | |||||
| Common stock, $0.001 par value per share; 70,000,000 shares authorized as of December 31, 2025 and December 31, 2024; 41,265,778 shares and 29,767,561 shares issued and outstanding as of December 31, 2025 and December 31, 2024 | $41.0K | $30.0K | ||||
| Additional paid-in capital | $1.1B | $931.3M | ||||
| Accumulated other comprehensive income | $69.0K | |||||
| Accumulated deficit | -$1.0B | -$947.9M | ||||
| Total stockholders' equity (deficit) | $61.0M | -$16.6M | $35.8M | |||
| Total liabilities, temporary equity and stockholders' equity (deficit) | $126.3M | $100.4M | ||||
| Temporary equity, par or stated value per share (in dollars per share) | $0.00 | $0.00 | ||||
| Temporary equity, shares issued | 0 shares | 12.0K shares | ||||
| Temporary equity, shares outstanding | 0 shares | 12.0K shares | ||||
| Common stock, par value per share (in dollars per share) | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Common stock, shares authorized | 70.0M shares | 70.0M shares | 1.4B shares | 70.0M shares | ||
| Common stock, shares issued | 41.3M shares | 29.8M shares | ||||
| Common stock, shares outstanding | 41.3M shares | 29.8M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.6
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$69.1M | -$78.6M |
| Depreciation and amortization expense | $1.5M | $1.5M |
| Non-cash interest expense (debt discount and deferred costs) | $1.4M | $3.8M |
| Net amortization of premiums and accretion of discounts on marketable securities | -$1.4M | -$1.3M |
| Gain on change in fair value of derivatives | -$102.0K | |
| Stock-based compensation expense | $10.2M | $9.2M |
| Provision for inventory obsolescence and losses | $694.0K | $3.9M |
| Allowance for credit losses | $931.0K | $220.0K |
| Accounts receivable | -$6.8M | -$2.7M |
| Prepaid expenses and other current assets | $1.5M | $1.2M |
| Inventory | -$3.0M | $696.0K |
| Deposits and other assets | $13.0K | $1.7M |
| Accounts payable | $1.2M | -$1.8M |
| Accrued expenses and other liabilities | $5.2M | $2.6M |
| Accrued interest | -$490.0K | $86.0K |
| Payments on lease liabilities | -$939.0K | -$912.0K |
| Net cash used in operating activities | -$59.1M | -$60.5M |
| Capital expenditures | -$1.1M | -$2.2M |
| Purchase of marketable securities | -$100.7M | -$58.0M |
| Proceeds from sale and maturity of marketable securities | $48.4M | $93.1M |
| Net cash (used in) provided by investing activities | -$53.4M | $32.8M |
| Proceeds from exercise of stock options, RSUs and ESPP issuances, net | $143.0K | $179.0K |
| Proceeds from issuance of term loan, net | $9.9M | |
| Taxes paid related to net share settlement of equity awards | -$1.7M | -$1.7M |
| Repayment of 2025 Notes | -$20.4M | |
| Proceeds from issuance of the RD Shares and the PP Warrants | $14.5M | |
| Payment of debt modification costs | -$412.0K | |
| Net cash provided by financing activities | $78.2M | $26.8M |
| Net decrease in cash and cash equivalents | -$34.4M | -$797.0K |
| Cash paid during the period for interest | $4.0M | $4.5M |
| Issuance of common stock converted from preferred shares | $30.4M | |
| Property and equipment purchases included in accounts payable and accrued expenses | $54.0K | $418.0K |
| Issuance of warrants for Loan and Security Agreement | $149.0K | |
| Change in exercise price of warrants due to Amended Loan and Security Agreement | -$163.0K | |
| Acquisition of sensor insertion network assets in exchange for accounts receivable | $725.0K | |
| Liabilities for contingent consideration | $50.0K |
No quarter-by-quarter statement was filed.
Leadership
Who has led Senseonics (United States), and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
- Chief executive officerTimothy T. Goodnow Apr 14, 2016 to now18
- PresidentTimothy T. Goodnow Mar 17, 2016 to now19
- Chief financial officerFrederick T. Sullivan Sep 6, 2022 to now20
- Chief financial officerNick B. Tressler Nov 19, 2019 to May 31, 202221
- Chief financial officerR. Don Elsey Mar 17, 2016 to Feb 5, 201822
- Chief operating officerMukul Jain Jan 23, 2017 to now23
Board members and other officers (20)
- Chief Commercial OfficerBrian B. Hansen May 21, 2026 to now24
- GC & Corp. Development AdvisorKenneth L. Horton Mar 15, 2021 to now25
- Chief Medical OfficerFrancine Kaufman Mar 6, 2019 to now26
- Vice President of U.S. SalesMichael J. Gill Apr 19, 2017 to Jan 22, 201927
- Chief Medical OfficerLynne E. Kelley Mar 17, 2016 to Feb 5, 201828
- VP Global Sales & MarketingMirasol Panlilio Mar 17, 2016 to Feb 14, 202229
- VP Operations, Qual & RegMukul Jain Mar 17, 2016 to Apr 14, 201630
- Board memberBrian B. Hansen Apr 1, 2024 to now31
- Board memberJohn Marotta Nov 2, 2022 to Nov 2, 202232
- Board memberSharon Larkin Dec 10, 2021 to now33
- Board memberFrancine Kaufman Jul 22, 2020 to now34
- Board memberAnthony R. Raab Oct 5, 2020 to May 24, 202435
- Board memberRobert Schumm Oct 5, 2020 to Oct 5, 202036
- Board memberDouglas A. Roeder Mar 17, 2016 to now37
- Board memberDouglas S. Prince Mar 17, 2016 to now38
- Board memberM. James Barrett Mar 17, 2016 to Jun 3, 201939
- Board memberPeter Justin Klein Mar 17, 2016 to Apr 5, 202140
- Board memberStephen P. Defalco Mar 17, 2016 to now41
- Board memberTimothy T. Goodnow Mar 17, 2016 to now19
- Board memberEdelman Steven Sep 6, 2016 to now42
Named in SEC Form D filings
People the company listed in its private-offering notices.
Former names
Timeline
Filings
392 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 55 major events, 238 insider forms, 12 large holders, 2 private raises, 65 other. The latest 20:
- Oct 5, 20264 EDGAR
- Oct 5, 20264 EDGAR
- Oct 5, 20264 EDGAR
- Oct 5, 20264 EDGAR
- Aug 20, 20264 EDGAR
- Aug 14, 2026SCHEDULE 13G EDGAR
- Aug 6, 202610-Q EDGAR
- Aug 6, 20268-K EDGAR
- Jul 30, 2026SCHEDULE 13G EDGAR
- Jul 2, 20264 EDGAR
- Jul 2, 20264 EDGAR
- Jul 2, 20264 EDGAR
- Jul 2, 20264 EDGAR
- Jun 17, 20264 EDGAR
- Jun 17, 20264 EDGAR
- Jun 17, 20264 EDGAR
- Jun 17, 20264 EDGAR
- Jun 17, 20264 EDGAR
- Jun 17, 20264 EDGAR
- Jun 8, 20268-K EDGAR
The 392 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
26 open-market trades by officers, directors and large owners since October 2021: 14 buys and 12 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | ROEDER DOUGLAS ADirector | Buy | 13,953 | $8.98 | $125.3K | Form 4 |
| May 12, 2026 | ROEDER DOUGLAS ADirector | Buy | 22,686 | $5.56 | $126.1K | Form 4 |
| Mar 13, 2026 | Goodnow Timothy TPresident and CEO | Buy | 17,225 | $5.79 | $99.7K | Form 4 |
| Mar 13, 2026 | ROEDER DOUGLAS ADirector | Buy | 17,500 | $5.73 | $100.3K | Form 4 |
| Nov 10, 2025 | Steven EdelmanDirector | Buy | 10,000 | $6.55 | $65.5K | Form 4 |
| Nov 7, 2025 | Sullivan Frederick T.Chief Financial Officer | Buy | 5,415 | $5.88 | $31.8K | Form 4 |
| Nov 7, 2025 | Goodnow Timothy TPresident and CEO | Buy | 17,210 | $5.87 | $101.0K | Form 4 |
| Nov 7, 2025 | ROEDER DOUGLAS ADirector | Buy | 15,000 | $5.83 | $87.5K | Form 4 |
| Dec 13, 2024 | ROEDER DOUGLAS ADirector | Buy | 75,000 | $0.50 | $37.5K | Form 4 |
| Dec 13, 2024 | ROEDER DOUGLAS ADirector | Buy | 25,000 | $0.50 | $12.5K | Form 4 |
| Dec 12, 2024 | ROEDER DOUGLAS ADirector | Buy | 300,000 | $0.41 | $123.0K | Form 4 |
| Dec 12, 2024 | Sullivan Frederick T.Chief Financial Officer | Buy | 124,933 | $0.38 | $47.5K | Form 4 |
| Dec 10, 2024 | Goodnow Timothy TPresident and CEO | Buy | 315,000 | $0.31 | $97.7K | Form 4 |
| Sep 7, 2023 | Larkin SharonDirector | Sale | 30,889 | $0.61 | $18.8K | Form 4 |
| Aug 30, 2023 | ROEDER DOUGLAS ADirector | Buy | 300,000 | $0.54 | $162.0K | Form 4 |
| Aug 4, 2022 | JAIN MukulChief Operating Officer | Sale | 50,000 | $1.97 | $98.5K | Form 4 |
| Mar 11, 2022 | Fiorentino EdwardDirector | Sale | 63,553 | $1.65 | $104.9K | Form 4 |
| Feb 11, 2022 | Tressler Nick B.Chief Financial Officer | Sale | 72,873 | $2.46 | $179.3K | Form 4 |
| Feb 11, 2022 | Panlilio MirasolVP Global Sales and Marketing | Sale | 105,760 | $2.46 | $260.2K | Form 4 |
| Feb 11, 2022 | Kaufman FrancineChief Medical Officer | Sale | 163,870 | $2.46 | $403.1K | Form 4 |
All 26 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Sessa Capital IM, L.P.SCHEDULE 13G, 1 filing Aug 14, 202644
- BlackRockSCHEDULE 13G, 1 filing Jul 30, 202645
- Robert J. SmithSCHEDULE 13G/A, 2 filings Apr 10, 2023 to Aug 8, 202546
- VANGUARD GROUP INCSC 13G/A, 2 filings Feb 9, 2023 to Feb 13, 202447
- PHC Holdings CorpSC 13D/A, 1 filing Mar 20, 202348
- GILDER GAGNON HOWE & CO LLCSC 13G/A, 1 filing Feb 14, 202249
- HIGHBRIDGE CAPITAL MANAGEMENT LLCSC 13G/A, 1 filing Feb 11, 202250
Money raised
Private offerings the company reported to the SEC on Form D.
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Sessa Capital IM, L.P. | 4,437,532 | $25.2M | 0.4% | +2,671,439 |
| BlackRock, Inc. | 2,793,558 | $15.9M | 0.0% | +2,224,829 |
| Vanguard Capital Management LLC | 1,779,398 | $10.1M | 0.0% | +162,201 |
| Avidity Partners Management LP | 1,600,000 | $9.1M | 1.5% | New |
| Sio Capital Management, LLC | 1,592,692 | $9.0M | 1.6% | +1,476,908 |
| UBS Group AG | 1,487,429 | $8.4M | 0.0% | +1,039,200 |
| Geode Capital Management, LLC | 1,132,210 | $6.4M | 0.0% | +665,695 |
| Masters Capital Management LLC | 700,000 | $4.0M | 0.6% | +200,000 |
| State Street Corp | 511,117 | $2.9M | 0.0% | +330,836 |
| Marshall Wace, Llp | 405,695 | $2.3M | 0.0% | −58,680 |
| Bank Of America Corp /de/ | 394,465 | $2.2M | 0.0% | +337,501 |
| Charles Schwab Investment Management Inc | 393,211 | $2.2M | 0.0% | +172,034 |
| Northern Trust Corp | 332,266 | $1.9M | 0.0% | +249,989 |
| Vanguard Fiduciary Trust Co | 331,353 | $1.9M | 0.0% | +106,186 |
| Walleye Capital LLC | 324,264 | $1.8M | 0.0% | New |
| Vanguard Portfolio Management LLC | 272,375 | $1.5M | 0.0% | New |
| Goldman Sachs Group Inc | 231,509 | $1.3M | 0.0% | +85,227 |
| Morgan Stanley | 164,984 | $937.1K | 0.0% | +41,041 |
| Russell Investments Group, Ltd. | 153,216 | $870.3K | 0.0% | +153,209 |
| Trexquant Investment LP | 135,128 | $767.5K | 0.0% | New |
| Ghisallo Capital Management LLC | 125,000 | $710.0K | 0.0% | New |
| Readystate Asset Management LP | 101,000 | $573.7K | 0.0% | New |
| Penn Capital Management Company, LLC | 94,140 | $534.7K | 0.0% | New |
| Sei Investments Co | 85,738 | $487.0K | 0.0% | +36,146 |
| Bank of New York Mellon Corp | 84,483 | $479.9K | 0.0% | New |
13F reports cover disclosed long positions in U.S. stocks only.
Links
- Websitesenseonics.com1
- WikidataQ30261278
- SEC EDGARCIK 1616543
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4Company websiteSenseonics (United States) photo
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19SEC EDGARTimothy T. Goodnow, President
- 20
- 21
- 22
- 23SEC EDGARMukul Jain, Chief operating officer
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31SEC EDGARBrian B. Hansen, Board member
- 32SEC EDGARJohn Marotta, Board member
- 33SEC EDGARSharon Larkin, Board member
- 34SEC EDGARFrancine Kaufman, Board member
- 35SEC EDGARAnthony R. Raab, Board member
- 36SEC EDGARRobert Schumm, Board member
- 37SEC EDGARDouglas A. Roeder, Board member
- 38SEC EDGARDouglas S. Prince, Board member
- 39SEC EDGARM. James Barrett, Board member
- 40SEC EDGARPeter Justin Klein, Board member
- 41SEC EDGARStephen P. Defalco, Board member
- 42SEC EDGAREdelman Steven, Board member
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50